Mesenchymal stem cell therapy in the treatment of hiposteoarthritis

By | 2018-07-16T16:49:36+00:00 July 16th, 2018|Mesenchymal Stem Cells, Osteoarthritis|Comments Off on Mesenchymal stem cell therapy in the treatment of hiposteoarthritis

Osteoarthritis (OA) is the most common joint disease and a major cause of disability. According to the National Health Interview Survey, more than 50 million adults have been diagnosed with OA in the United States in 2012.1

[pdf-embedder url=”https://www.nsorm.com/wp-content/uploads/2018/07/MSCs-in-Tx-of-Hip-Osteoarthritis-Mar-2017.pdf” title=”MSC’s in Tx of Hip Osteoarthritis Mar 2017″]

About the Author: